Understanding the Clinical Microbiology Laboratory Carol R. Quinter Ph.D. January, 2007.

Slides:



Advertisements
Similar presentations
Medication Management
Advertisements

Trends in fungal disease in the UK Theresa Lamagni Healthcare-Associated Infection & Antimicrobial Resistance Department HPA Centre for Infections.
Office of Infectious Diseases Computational Challenges for Infectious Diseases Michael Shaw, PhD OID/Office of the Director.
Foundations in Microbiology Seventh Edition
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Role of the laboratory in disease surveillance
Subtle Imipenem Resistance In an ICU Outbreak of Acinetobacter-baumanii calcoaceticus (ACBC) Sandy J. Close, Pharm.D., BCPS, Steven J. Martin, Pharm.D.,
 A public health science (foundation of public health)  Impacts personal decisions about our lifestyles  Affects government, public health agency and.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Molecular Diagnosis of Infectious Diseases. Why use a molecular test to diagnose an infectious disease? Need an accurate and timely diagnosis Important.
Diagnostic Microbiology and Immunology
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Practical application of laboratory results in infection prevention and healthcare epidemiology Richard A. Van Enk, Ph.D., CIC Director, Infection Prevention.
CHAPTER 25 Epidemiology. Principles of Epidemiology The Science of Epidemiology Epidemiology is the study of disease in populations. To understand infectious.
Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.
Epidemiology and Public Health Nester Chapter 20 Notebook, Page 281.
The Nature of Disease.
Clindamycin induction test in treating patients infected with methicilin resistant Staphylococcus aureus Presented by Iyad Kaddora.
Epidemiology.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
SCIENTIFIC KNOWLEDGE BASE  ENTRY AND MULTIPLICATION OF ORGANISM RESULTS IN DISEASE  COLONIZATION OCCURS WHEN A MICROORGANISM INVADES THE HOST BUT DOES.
Infection Control Clinical Pharmacy and Patient Safety
 A public health science (foundation of public health)  Impacts personal decisions about our lifestyles  Affects government, public health agency and.
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
In Vitro Testing of Antimicrobial Agents Maryam Monajemzadeh, Pathologist Children Medical Center Hospital Tehran University Of Medical Sciences.
Biomedical Research.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Dr K N Prasad Community Medicine
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Infectious Disease Epidemiology, Module I Introduction.
KIRBY – BAUER MINIMUM INHIBITORY CONCENTRATION MINIMUM BACTERIOCIDAL CONCENTRATION.
MLAB 2434 – MICROBIOLOGY KERI BROPHY-MARTINEZ Microscopic Examination of Infected Materials.
Factors That Influence Epidemics Transmission and The Role of Nurses in the Identification of an Epidemic.
Unit 6: Specialised Techniques: Anti-Microbial Resistance Monitoring and Assessment of STI Syndrome Aetiologies #4-6-1.
MLAB Microbiology Keri Brophy-Martinez Public Health & The Microbiology Lab.
Basic Nursing: Foundations of Skills & Concepts Chapter 9
Laboratory Training for Field Epidemiologists Cultivation of parasites Investigation strategies and methods May 2007.
Methods for detecting resistance Goal: To determine whether organism expresses resistances to agents potentially used for therapy Designed to determine.
Epidemiology. Epidemiological studies involve: –determining etiology of infectious disease –reservoirs of disease –disease transmission –identifying patterns.
Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
Epidemiology. Classically speaking Classically speaking EPI DEMO LOGOS Upon,on,befall People,population,man the Study of The study of anything that happens.
ANTIMICROBIALS Chapter 10.
Nosocomial infection Hospital acquired infections.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
By: Dr. Khalid El Tohami. Objectives  At the end of the session the student should be able to:  Define epidemiology, what are the basic measurements.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Foundations in Microbiology Seventh Edition
Antimicrobial Stewardship
Comply with Infection Control Policies and Procedures in Health Work
Introduction to Lab Quality
Outbreak Investigations
Antimicrobial Susceptibility Testing (AST)
Ashry Gad Mohamed Prof. of Epidemiology
This is an archived document.
Principles of Antimicrobial use and Drug Resistance Omilabu S.A, Ph.D Department of Medical Microbiology and Parasitology, CMUL. 16 th January 2015.
Principles of Medical Microbiology
AST SC’s Perspective on the Development and Use of ECVs
Hospital Antibiotic Stewardship Programs
Care of Patients with Infection
Introduction To Medical Technology
ANTIBIOTIC RESISTANCE
Introduction to public health surveillance
Principles of Antimicrobial Therapy
Molecular Testing and Therapeutic Management in the Treatment of Infectious Disease Leveraging the latest science and a team-based approach to improve.
Presentation transcript:

Understanding the Clinical Microbiology Laboratory Carol R. Quinter Ph.D. January, 2007

Is This Possible?!!

The Role of the Clinical Microbiology Laboratory Clarify the presence of infection Clarify the presence of infection Specify the etiology Specify the etiology Motivate the appropriate selection of antimicrobic Motivate the appropriate selection of antimicrobic Promote the appropriateness of use of antimicrobic Promote the appropriateness of use of antimicrobic Assist in the identification, control, and prevention of nosocomial infections Assist in the identification, control, and prevention of nosocomial infections Assist in the identification, control, and prevention of infections in the community Assist in the identification, control, and prevention of infections in the community The quality microbiology laboratory will lead a physician to a specific diagnosis by requiring quality specimens which result in relevant information which when communicated in a timely manner results in appropriate therapy.

Responsibility Accurate, Clinically Relevant, Timely Data Garbage In—Garbage Out 250 million annually is wasted by the processing of improperly obtained and clinically irrelevant specimens, which results in: 250 million annually is wasted by the processing of improperly obtained and clinically irrelevant specimens, which results in:

Bad Information Becomes part of a patient’s medical record Becomes part of a patient’s medical record Has little value in patient care Has little value in patient care Perpetuates the misuse and overuse of antimicrobials Perpetuates the misuse and overuse of antimicrobials Contributes to the morbidity and mortality of nosocomial infections Contributes to the morbidity and mortality of nosocomial infections Has an adverse effect on length of stay Has an adverse effect on length of stay Has a negative effect on quality of care and patient outcome Has a negative effect on quality of care and patient outcome

Function of the Microbiology Laboratoy Determine the Etiology of the Infectious Process Microscopic Examination Microscopic Examination Culture Culture Immunochemical Immunochemical Molecular Molecular

Microscopic Examination Gram-stained Smear: Timely Timely Presumptive identification of etiology Presumptive identification of etiology Drives empiric therapy Drives empiric therapy Assesses quality of specimen and predicts clinical relevance of culture results Assesses quality of specimen and predicts clinical relevance of culture results Guide to the determination of colonization vs. infection Guide to the determination of colonization vs. infection

Interpretation of Gram-stained Smear Adequacy of specimen measured by presence of inflammation (WBC, RBC, Necrotic Debris) Adequacy of specimen measured by presence of inflammation (WBC, RBC, Necrotic Debris) Presence of epithelial elements may indicate specimen inadequacy. Look for ratio of 2:1, WBC:Epi Presence of epithelial elements may indicate specimen inadequacy. Look for ratio of 2:1, WBC:Epi Morphologic diversity of organisms present and their relative numbers is important and can provide important clinical clues Morphologic diversity of organisms present and their relative numbers is important and can provide important clinical clues Focus on predominant morphologic type(s) Focus on predominant morphologic type(s) Alert to unusual pathogen Alert to unusual pathogen

Normal Flora Specimens which are obtained from or through areas where normal flora exists, will grow normal flora. Normal flora is predictable and changes within 24 hours of hospitalization to hospital flora. All infectious agents establish themselves at portals of entry, prior to producing infection, hence become: “normal flora” Accessible sites to culture usually have large numbers of normal flora.

Dilemma of Colonization vs. Infection All data must be interpreted clinically.

Culture Historic, remains gold standard Historic, remains gold standard Not timely Not timely Laboratory is adverse environment Laboratory is adverse environment Host is adverse environment Host is adverse environment Depends on the laboratory’s ability to provide the organism with favorable conditions to grow Depends on the laboratory’s ability to provide the organism with favorable conditions to grow

Immunochemical Monoclonal Antibodies Substances (antigens) foreign to the body invoke the production of antibodies which are highly specific. Substances (antigens) foreign to the body invoke the production of antibodies which are highly specific. Monoclonal antibody technology allows us to produce large amounts of pure antibody which reacts to a specific antigen. Monoclonal antibody technology allows us to produce large amounts of pure antibody which reacts to a specific antigen.

Principal Tools Direct Fluorescent Antibody Direct Fluorescent Antibody Indirect Fluorescent Antibody Indirect Fluorescent Antibody ELISA ELISA Sensitivity—The ability to detect Sensitivity—The ability to detect Specificity—The ability to detect precisely Specificity—The ability to detect precisely

How Does It Work?

Pearls A positive is a postive A positive is a postive A negative means further testing A negative means further testing

Molecular Probes Probes Amplification—Gene or Signal Amplification—Gene or Signal Pulse Gel Pulse Gel

Usefulness of Molecular Technology Rapid diagnosis of infection, particularly in sterile body sites and particularly where numbers of organisms may be low and culture difficult Rapid diagnosis of infection, particularly in sterile body sites and particularly where numbers of organisms may be low and culture difficult Characterization of strains for epidemiologic purposes Characterization of strains for epidemiologic purposes Rapid identification of isolates which otherwise require complex procedures which are costly and take too much time Rapid identification of isolates which otherwise require complex procedures which are costly and take too much time Appropriate designation of genus and species of organisms Appropriate designation of genus and species of organisms Detection of resistance Detection of resistance

Susceptibility Testing Minimum Inhibitory Concentration Minimum Inhibitory Concentration MIC - Lowest Concentration of antimicrobic which will inhibit in vitro growth of microorganism. Minimum Bacteriocidal Concentration Minimum Bacteriocidal Concentration MBC -Lowest Concentration of antimicrobic which will kill a microorganism in vitro.

Tolerance The relationship of MIC to MBC in any drug/bug combination.

Interpretation of MIC Based on achievable concentration of antimicrobic following IM injection in healthy subjects. In general, the achievable in vivo concentration should be 2 to 4 times the MIC for an organism to test susceptible to the antimicrobic. The Therapeutic Index is the relationship of MIC to antimicrobic level.

The Future Infectious diseases continue to impose a huge global public health burden, accounting for more than one-quarter of all deaths annually and similar fraction of morbidity. Infectious diseases continue to impose a huge global public health burden, accounting for more than one-quarter of all deaths annually and similar fraction of morbidity.

Challenges New and changing pathogens New and changing pathogens Global eradication of old pathogens Global eradication of old pathogens Developing diagnostics Developing diagnostics Developing treatments and preventions and managing resistance Developing treatments and preventions and managing resistance Control of infections within institutions and other closed settings and designing effective surveillance strategies Control of infections within institutions and other closed settings and designing effective surveillance strategies Control of infectious disease outbreaks Control of infectious disease outbreaks Understanding the role of animal and insect reservoirs Understanding the role of animal and insect reservoirs Prevention of bioterrorism Prevention of bioterrorism